These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8950754)

  • 21. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ras-responsive genes and tumor metastasis.
    Chambers AF; Tuck AB
    Crit Rev Oncog; 1993; 4(2):95-114. PubMed ID: 8420573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
    Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
    Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ras regulatory interactions: novel targets for anti-cancer intervention?
    Prendergast GC; Gibbs JB
    Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
    Yokoyama T
    Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
    Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
    Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?
    Shinohara N; Koyanagi T
    Urol Res; 2002 Oct; 30(5):273-81. PubMed ID: 12389114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An experimental analysis of cancer: role of ras oncogenes in multistep carcinogenesis.
    Sukumar S
    Cancer Cells; 1990 Jul; 2(7):199-204. PubMed ID: 2204384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ras signal transduction pathway.
    Khosravi-Far R; Der CJ
    Cancer Metastasis Rev; 1994 Mar; 13(1):67-89. PubMed ID: 8143346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing complexity of Ras signaling.
    Campbell SL; Khosravi-Far R; Rossman KL; Clark GJ; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1395-413. PubMed ID: 9779987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    J Toxicol Environ Health; 1991 Nov; 34(3):367-84. PubMed ID: 1658350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
    Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting the different biological effects of oncogenic Ras isoforms in cancer cell lines: could stimulation of oxidative stress be the one more weapon of H-Ras? Regulation of oxidative stress and Ras biological effects.
    Bellavia M; Gioviale MC; Damiano G; Palumbo VD; Spinelli G; Buscemi G; Lo Monte AI
    Med Hypotheses; 2012 Dec; 79(6):731-4. PubMed ID: 22981836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse models of K-ras-initiated carcinogenesis.
    Janssen KP; Abal M; El Marjou F; Louvard D; Robine S
    Biochim Biophys Acta; 2005 Nov; 1756(2):145-54. PubMed ID: 16126346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAS mutations in human cancers: Roles in precision medicine.
    Murugan AK; Grieco M; Tsuchida N
    Semin Cancer Biol; 2019 Dec; 59():23-35. PubMed ID: 31255772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the isoprenoid pathway in ras transforming activity, cytoskeleton organization, cell proliferation and apoptosis.
    Bifulco M
    Life Sci; 2005 Aug; 77(14):1740-9. PubMed ID: 15955538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic signaling pathways and deregulated target genes.
    Schäfer R; Schramme A; Tchernitsa OI; Sers C
    Recent Results Cancer Res; 2007; 176():7-24. PubMed ID: 17607912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.